NDWM LLC
IBB icon

NDWM LLC’s iShares Biotechnology ETF IBB Stock Holding History

NDWM LLC’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.46M Buy
+6,931
New +$1.39M 0.84% 23

Other funds holding IBB

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
WestEnd Advisors
WestEnd Advisors Charlotte, North Carolina $4.53B AUM 12.98% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

NDWM LLC's IBB Position: Q3 2026 in Review

NDWM LLC opened a new position in iShares Biotechnology ETF (IBB) in Q3 2026: 6,931 shares worth $1.46M. The stake represents 0.84% of the portfolio and ranks #23 among its holdings.

713 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • NDWM LLC held 6,931 shares of iShares Biotechnology ETF worth $1.46M as of Q3 2026.
  • iShares Biotechnology ETF was a new NDWM LLC position in Q3 2026.
  • iShares Biotechnology ETF made up 0.84% of NDWM LLC's portfolio in Q3 2026, its #23 holding.
  • 713 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on NDWM LLC's 13F filing for Q3 2026, filed 5 Nov 2026.